Increased Immunogenicity of an Anchor-Modified Tumor-Associated Antigen Is Due to the Enhanced Stability of the Peptide/MHC Complex: Implications for Vaccine Design
Borbulevych, O.Y., Baxter, T.K., Yu, Z., Restifo, N.P., Baker, B.M.(2005) J Immunol 174: 4812-4820
- PubMed: 15814707 
- DOI: 10.4049/jimmunol.174.8.4812
- Primary Citation of Related Structures:  
1TVB, 1TVH - PubMed Abstract: 
The use of "anchor-fixed" altered peptide ligands is of considerable interest in the development of therapeutic vaccines for cancer and infectious diseases, but the mechanism by which successful altered peptide ligands elicit enhanced immunity is unclear ...